Please login to the form below

Not currently logged in
Email:
Password:

GSK's Lawson elected PAGB president

He will help lead OTC trade body after departure of Novartis' David Barnett
pagb Carlton Lawson

The Proprietary Association of Great Britain (PAGB), which represents OTC companies in the UK, has elected Carlton Lawson of GlaxoSmithKline (GSK) as its new president.

On March 3 Lawson, who is general manager of GSK's consumer health business in the UK and Ireland, will take over from Novartis' David Barnett who moves to a new position in Latin America.

Lawson was only appointed to his current GSK position last year having previously served as global business lead in oral heath at the healthcare giant.

This followed a career that included senior sales and brand roles at Warner Lamber, Pfizer and Johnson & Johnson. He has experience with the PAGB too, being elected vice president in 2007.

Matthew Speers, chief executive of the PAGB, said he was “looking forward to working with Lawson”.

“Having served on the PAGB board previously when he was general manager at Johnson & Johnson, he has in-depth knowledge of PAGB and this past experience will be a great asset in helping drive forward PAGB's work programme, particularly the better regulation agenda,” said Speers.

26th February 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics